Legislative record
A 4852STATE · New JerseyIntroduced
Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*
Voted 7/8/2026View source
Summary
No summary has been published for this bill yet.
Bill text
The full text of this bill isn't on Heard yet. The official documents are linked below.
- IntroducedOfficial document (PDF)
- Assembly Committee SubstituteOfficial document (HTML)
- StatementOfficial document (HTML)
- Assembly Committee SubstituteOfficial document (PDF)
- StatementOfficial document (PDF)
- IntroducedOfficial document (HTML)
- Pamphlet LawOfficial document (PDF)
- Pamphlet LawOfficial document (HTML)
- Advance LawOfficial document (PDF)
- Advance LawOfficial document (HTML)
Roll-call record
How representatives voted
0 yea·0 nay
No roll-call votes recorded for this bill yet.
Docket history
Action history
- 7/8/2026Approved P.L.2026, c.40.
- 6/30/2026Passed by the Assembly (76-2-1)
- 6/30/2026Passed Senate (Passed Both Houses) (38-2)
- 6/30/2026Received in the Senate without Reference, 2nd Reading
- 6/30/2026Substituted for S4194/4210 (SCS)
- 6/23/2026Transferred to Assembly State and Local Government Committee
- 6/23/2026Reported from Assembly Comm. as a Substitute, 2nd Reading
- 5/4/2026Introduced, Referred to Assembly Health Committee